(MUR) Murphy Oil - Ratings and Ratios
Crude Oil, Natural Gas, Natural Gas Liquids
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 45.7% |
| Value at Risk 5%th | 73.0% |
| Relative Tail Risk | -2.93% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.12 |
| Alpha | -19.52 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.481 |
| Beta | 1.426 |
| Beta Downside | 2.016 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.46% |
| Mean DD | 24.62% |
| Median DD | 20.59% |
Description: MUR Murphy Oil November 08, 2025
Murphy Oil Corporation (NYSE:MUR) is a Houston-based integrated upstream firm that explores for and produces crude oil, natural gas, and natural gas liquids across the United States, Canada, and select international locations. The company, incorporated in 1950 and renamed in 1964, operates under the GICS sub-industry “Oil & Gas Exploration & Production.”
Recent operational data show average net production of roughly 150,000 barrels of oil equivalent per day (boe/d) in 2023, with a 65/35 split between oil and natural gas. Cash flow from operations for the year exceeded $600 million, and the balance sheet carries a debt-to-equity ratio near 0.7, reflecting moderate leverage. Key sector drivers for Murphy include the trajectory of WTI crude prices, regional gas price spreads, and capital-intensity trends in the Permian and Gulf of Mexico basins.
If you’re looking for a data-driven, quick-look valuation, the ValueRay profile on Murphy Oil can provide a useful next step for deeper analysis.
MUR Stock Overview
| Market Cap in USD | 4,209m |
| Sub-Industry | Oil & Gas Exploration & Production |
| IPO / Inception | 1983-04-06 |
| Return 12m vs S&P 500 | -13.4% |
| Analyst Rating | 3.0 of 5 |
MUR Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 4.34% |
| Yield on Cost 5y | 14.49% |
| Yield CAGR 5y | 17.02% |
| Payout Consistency | 68.1% |
| Payout Ratio | 83.0% |
MUR Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | -10.63% |
| CAGR/Max DD Calmar Ratio | -0.18 |
| CAGR/Mean DD Pain Ratio | -0.43 |
| Current Volume | 1690.4k |
| Average Volume | 2002.1k |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (142.7m TTM) > 0 and > 6% of Revenue (6% = 164.8m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -13.74pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1830 % (prev -8.00%; Δ -1822 pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 340.52b > Net Income 142.7m (YES >=105%, WARN >=100%) |
| Current Ratio 0.94 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (142.7m) change vs 12m ago -5.07% (target <= -2.0% for YES) |
| Gross Margin 37.71% (prev 37.36%; Δ 0.35pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 0.06% (prev 32.84%; Δ -32.79pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.99 (EBITDA TTM 1.32b / Interest Expense TTM 117.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.71
| (A) -0.01 = (Total Current Assets 807.48b - Total Current Liabilities 857.75b) / Total Assets 9732.76b |
| (B) 0.69 = Retained Earnings (Balance) 6725.83b / Total Assets 9732.76b |
| (C) 0.00 = EBIT TTM 349.5m / Avg Total Assets 4871.24b |
| (D) 1.42 = Book Value of Equity 6346.00b / Total Liabilities 4483.11b |
| Total Rating: 3.71 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 45.34
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield 18.93% = 5.0 |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.42 = 2.41 |
| 5. Debt/Ebitda data missing |
| 6. ROIC - WACC (= -0.02)% = -0.02 |
| 7. RoE 0.01% = 0.00 |
| 8. Rev. Trend -86.37% = -6.48 |
| 9. EPS Trend -81.54% = -4.08 |
What is the price of MUR shares?
Over the past week, the price has changed by +6.46%, over one month by +11.40%, over three months by +38.78% and over the past year by -1.58%.
Is MUR a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 13
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the MUR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 28.3 | -6.7% |
| Analysts Target Price | 28.3 | -6.7% |
| ValueRay Target Price | 31.1 | 2.4% |
MUR Fundamental Data Overview November 15, 2025
P/E Trailing = 29.49
P/E Forward = 42.3729
P/S = 1.5327
P/B = 0.8041
P/EG = 0.3062
Beta = 0.814
Revenue TTM = 2.75b USD
EBIT TTM = 349.5m USD
EBITDA TTM = 1.32b USD
Long Term Debt = 1.43b USD (from longTermDebt, last quarter)
Short Term Debt = 211.69b USD (from shortTermDebt, last quarter)
Debt = 2219.00b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1793.04b USD (from netDebt column, last quarter)
Enterprise Value = 1797.25b USD (4.21b + Debt 2219.00b - CCE 425.96b)
Interest Coverage Ratio = 2.99 (Ebit TTM 349.5m / Interest Expense TTM 117.0m)
FCF Yield = 18.93% (FCF TTM 340.21b / Enterprise Value 1797.25b)
FCF Margin = 12.4k% (FCF TTM 340.21b / Revenue TTM 2.75b)
Net Margin = 5.20% (Net Income TTM 142.7m / Revenue TTM 2.75b)
Gross Margin = 37.71% ((Revenue TTM 2.75b - Cost of Revenue TTM 1.71b) / Revenue TTM)
Gross Margin QoQ = 66.05% (prev 22.56%)
Tobins Q-Ratio = 0.18 (Enterprise Value 1797.25b / Total Assets 9732.76b)
Interest Expense / Debt = 0.00% (Interest Expense 24.7m / Debt 2219.00b)
Taxrate = -113.5% (out of range, set to none) (4.16m / -3.66m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 0.94 (Total Current Assets 807.48b / Total Current Liabilities 857.75b)
Debt / Equity = 0.42 (Debt 2219.00b / totalStockholderEquity, last quarter 5249.65b)
Debt / EBITDA = 1359 (out of range, set to none) (Net Debt 1793.04b / EBITDA 1.32b)
Debt / FCF = 5.27 (Net Debt 1793.04b / FCF TTM 340.21b)
Total Stockholder Equity = 1316.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.00% (Net Income 142.7m / Total Assets 9732.76b)
RoE = 0.01% (Net Income TTM 142.7m / Total Stockholder Equity 1316.29b)
RoCE = 0.03% (EBIT 349.5m / Capital Employed (Equity 1316.29b + L.T.Debt 1.43b))
RoIC = 0.00% (EBIT 349.5m / (Assets 9732.76b - Curr.Liab 857.75b - Cash 425.96b))
WACC = 0.02% (E(4.21b)/V(2223.21b) * Re(11.27%) + (debt cost/tax rate unavailable))
Discount Rate = 11.27% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.13%
[DCF Debug] Terminal Value 71.67% ; FCFE base≈204.80b ; Y1≈252.65b ; Y5≈431.05b
Fair Price DCF = 30.8k (DCF Value 4391.54b / Shares Outstanding 142.7m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -81.54 | EPS CAGR: -30.15% | SUE: 1.44 | # QB: 1
Revenue Correlation: -86.37 | Revenue CAGR: -10.76% | SUE: 1.26 | # QB: 2
Additional Sources for MUR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle